• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Academy
  • FAQ
  • News
  • Blog
  • Europe
    • United Kingdom
    • Spain
    • Italy
    • Portugal
    • Brazil
    • Colombia
    • Ecuador
    • Mexico
    • Argentina
    • Latin America
    • UAE
Veritas

Veritas

  • Services and Test
        • Preventive Medicine
          • myGenome
          • myGeneticRisk
          • myHealthScore
          • myPharma
        • Perinatal Medicine
          • myPrenatal
          • myNewborn
          • myBabyHealth
          • PregnancyLoss
          • PrenatalWES
        • Diagnostic Genetics Services
          • CardioRisk
          • CancerRisk
          • GenomeDx
          • ExomeDx
          • Targeted Panels
        • Genetic Counselling
          • Genetic Counselling
  • Medical Professionals
  • Partners
  • Experiences
  • About Veritas
  • CONTACT
LlámanosLlámanos
CALL US!
  • Europe

  • United Kingdom

  • Spain

  • Italy

  • Brazil

  • Portugal

  • Colombia

  • Ecuador

  • Mexico

  • Argentina

  • Latin America

  • Services & Test
    • Preventive Medicine
      • myGenome
      • myGeneticRisk
      • myHealthScore
    • Pregnancy & Early Childhood
      • myPrenatal
      • myNewborn
      • myBabyHealth
      • PregnancyLoss
    • Genetics Diagnostics
      • CardioRisk
      • CancerRisk
      • GenomeDx
      • ExomeDx
      • Targeted Panels
    • Genetic Counseling
  • Medical Professionals
  • Partners
  • Experiences
  • About Veritas
  • Academy
  • FAQ
  • News
  • Blog
  • Contact

News

A recent study demonstrates that genetic information provided by Whole Genome Sequencing (WGS) can help detect diseases at an earlier stage and give greater precision to screening and health optimization in general practice.

October 28, 2022

Veritas takes its innovative prevention based genetic services portfolio to the European Society of Human Genetics (ESHG) Conference 2022 and will present results from WGS genomic screenings in 400 patients from the Clínica Universidad de Navarra

June 9, 2022

Veritas and UAB PLACENTA awarded the KAUNAS CLINIC NIPT TENDER

April 4, 2022

Charme Capital Partners and Amadeus Capital Partners agree the sale of Veritas Intercontinental to LetsGetChecked

March 29, 2022

Veritas brings new clinical updates to myGenome, its whole genome sequencing based comprehensive genetic risk screening service.

October 26, 2021

Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have been in the news in recent days.

June 23, 2021

  • «
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 8
  • »

Footer

  • facebook
  • youtube
  • twitter
  • instagram
  • linkedin

VERITAS INTERCONTINENTAL – CALLE ORENSE 58, 2ºC-D, 28020 MADRID, ESPAÑA – CIF B88132907 – AUTHORIZED MEDICAL CENTER Registration Nº CS20242

  • Privacy policy and Legal Notice
  • General contracting conditions
  • Cookies Policy